ID   KCNA5_RAT               Reviewed;         602 AA.
AC   P19024; Q6LEB7;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 5;
DE   AltName: Full=RCK7;
DE   AltName: Full=RK4;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.5;
GN   Name=Kcna5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   TRANSPORTER ACTIVITY.
RC   TISSUE=Brain;
RX   PubMed=2361015; DOI=10.1016/0896-6273(90)90146-7;
RA   Swanson R., Marshall J., Smith J., Williams J., Boyle M.B., Folander K.,
RA   Luneau C.J., Antanavage J., Oliva C., Buhrow S.A., Bennett C., Stein R.B.,
RA   Kaczmarek L.M.;
RT   "Cloning and expression of cDNA and genomic clones encoding three delayed
RT   rectifier potassium channels in rat brain.";
RL   Neuron 4:929-939(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=1705709; DOI=10.1073/pnas.88.5.1798;
RA   Roberds S.L., Tamkun M.M.;
RT   "Cloning and tissue-specific expression of five voltage-gated potassium
RT   channel cDNAs expressed in rat heart.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1798-1802(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15.
RX   PubMed=8253777; DOI=10.1016/s0021-9258(19)74340-3;
RA   Mori Y., Matsubara H., Folco E., Siegel A., Koren G.;
RT   "The transcription of a mammalian voltage-gated potassium channel is
RT   regulated by cAMP in a cell-specific manner.";
RL   J. Biol. Chem. 268:26482-26493(1993).
RN   [4]
RP   INTERACTION WITH DLG1, AND MUTAGENESIS OF 600-THR--LEU-602.
RX   PubMed=11709425; DOI=10.1152/ajpheart.2001.281.6.h2575;
RA   Murata M., Buckett P.D., Zhou J., Brunner M., Folco E., Koren G.;
RT   "SAP97 interacts with Kv1.5 in heterologous expression systems.";
RL   Am. J. Physiol. 281:H2575-H2584(2001).
RN   [5]
RP   INTERACTION WITH DLG1 AND CAV3, AND FUNCTION IN CELL EXCITATION.
RX   PubMed=15277200; DOI=10.1152/ajpheart.00152.2004;
RA   Folco E.J., Liu G.-X., Koren G.;
RT   "Caveolin-3 and SAP97 form a scaffolding protein complex that regulates the
RT   voltage-gated potassium channel Kv1.5.";
RL   Am. J. Physiol. 287:H681-H690(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TRANSPORTER ACTIVITY.
RX   PubMed=15618540; DOI=10.1161/01.res.0000154070.06421.25;
RA   Plane F., Johnson R., Kerr P., Wiehler W., Thorneloe K., Ishii K., Chen T.,
RA   Cole W.;
RT   "Heteromultimeric Kv1 channels contribute to myogenic control of arterial
RT   diameter.";
RL   Circ. Res. 96:216-224(2005).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates transmembrane
CC       potassium transport in excitable membranes. Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance with
CC       their electrochemical gradient. The channel alternates between opened
CC       and closed conformations in response to the voltage difference across
CC       the membrane (PubMed:15618540, PubMed:2361015). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, and possibly other
CC       family members as well; channel properties depend on the type of alpha
CC       subunits that are part of the channel (PubMed:15618540). Channel
CC       properties are modulated by cytoplasmic beta subunits that regulate the
CC       subcellular location of the alpha subunits and promote rapid
CC       inactivation (PubMed:15618540). Homotetrameric channels display rapid
CC       activation and slow inactivation. Required for normal electrical
CC       conduction including formation of the infranodal ventricular conduction
CC       system and normal action potential configuration, as a result of its
CC       interaction with XIRP2 (By similarity). May play a role in regulating
CC       the secretion of insulin in normal pancreatic islets (By similarity).
CC       {ECO:0000250|UniProtKB:P22460, ECO:0000250|UniProtKB:Q61762,
CC       ECO:0000269|PubMed:15277200, ECO:0000269|PubMed:15618540,
CC       ECO:0000269|PubMed:2361015}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:15618540, ECO:0000269|PubMed:2361015};
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel proteins.
CC       Interacts with DLG1, which enhances channel currents (PubMed:11709425).
CC       Forms a ternary complex with DLG1 and CAV3 (PubMed:15277200). Interacts
CC       with KCNAB1 (By similarity). Interacts with UBE2I (By similarity).
CC       Interacts with XIRP2; the interaction is required for normal action
CC       potential configuration in the heart (By similarity).
CC       {ECO:0000250|UniProtKB:P22460, ECO:0000250|UniProtKB:Q61762,
CC       ECO:0000269|PubMed:11709425, ECO:0000269|PubMed:15277200}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15618540,
CC       ECO:0000269|PubMed:2361015}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed equally in atrium, ventricle, aorta and
CC       skeletal muscle. Weaker expression in brain.
CC       {ECO:0000269|PubMed:1705709}.
CC   -!- INDUCTION: Expression regulated by cAMP in a tissue-specific manner. In
CC       primary cardiac cells, levels increase by 6-fold, and in GH3 cells,
CC       levels decrease 5-6-fold.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the C-terminal PDZ-binding motif may
CC       play a role in modulation of channel activity and/or targeting of the
CC       channel to specific subcellular compartments.
CC   -!- DOMAIN: The transmembrane segment S4 functions as a voltage-sensor and
CC       is characterized by a series of positively charged amino acids at every
CC       third position. Channel opening and closing is effected by a
CC       conformation change that affects the position and orientation of the
CC       voltage-sensor paddle formed by S3 and S4 within the membrane. A
CC       transmembrane electric field that is positive inside would push the
CC       positively charged S4 segment outwards, thereby opening the pore, while
CC       a field that is negative inside would pull the S4 segment inwards and
CC       close the pore. Changes in the position and orientation of S4 are then
CC       transmitted to the activation gate formed by the inner helix bundle via
CC       the S4-S5 linker region. {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:P22460}.
CC   -!- PTM: Sumoylated on Lys-212, and Lys-525, preferentially with SUMO3.
CC       Sumoylation regulates the voltage sensitivity of the channel (By
CC       similarity). {ECO:0000250|UniProtKB:P22460}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker) (TC
CC       1.A.1.2) subfamily. Kv1.5/KCNA5 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27158; AAA41498.1; -; Genomic_DNA.
DR   EMBL; L23434; AAA42337.1; -; Genomic_DNA.
DR   PIR; JH0166; JH0166.
DR   RefSeq; NP_037104.1; NM_012972.1.
DR   AlphaFoldDB; P19024; -.
DR   SMR; P19024; -.
DR   BioGRID; 247503; 6.
DR   CORUM; P19024; -.
DR   IntAct; P19024; 4.
DR   MINT; P19024; -.
DR   STRING; 10116.ENSRNOP00000026691; -.
DR   ChEMBL; CHEMBL4295724; -.
DR   PhosphoSitePlus; P19024; -.
DR   PaxDb; 10116-ENSRNOP00000026691; -.
DR   ABCD; P19024; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000026691.3; ENSRNOP00000026691.1; ENSRNOG00000019719.3.
DR   Ensembl; ENSRNOT00055018093; ENSRNOP00055014535; ENSRNOG00055010709.
DR   Ensembl; ENSRNOT00060028378; ENSRNOP00060022849; ENSRNOG00060016571.
DR   Ensembl; ENSRNOT00065057506; ENSRNOP00065047347; ENSRNOG00065033450.
DR   GeneID; 25470; -.
DR   KEGG; rno:25470; -.
DR   UCSC; RGD:2953; rat.
DR   AGR; RGD:2953; -.
DR   CTD; 3741; -.
DR   RGD; 2953; Kcna5.
DR   eggNOG; KOG1545; Eukaryota.
DR   GeneTree; ENSGT00940000161860; -.
DR   HOGENOM; CLU_011722_4_0_1; -.
DR   InParanoid; P19024; -.
DR   OMA; MNNTLSC; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; P19024; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   Reactome; R-RNO-5576890; Phase 3 - rapid repolarisation.
DR   PRO; PR:P19024; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000019719; Expressed in skeletal muscle tissue and 10 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0014704; C:intercalated disc; IDA:RGD.
DR   GO; GO:0046691; C:intracellular canaliculus; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IMP:UniProtKB.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; IDA:RGD.
DR   GO; GO:0051393; F:alpha-actinin binding; ISO:RGD.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; ISO:RGD.
DR   GO; GO:0086087; F:voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization; ISO:RGD.
DR   GO; GO:0086090; F:voltage-gated potassium channel activity involved in SA node cell action potential repolarization; ISO:RGD.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; ISO:RGD.
DR   GO; GO:0060081; P:membrane hyperpolarization; ISO:RGD.
DR   GO; GO:0098914; P:membrane repolarization during atrial cardiac muscle cell action potential; ISO:RGD.
DR   GO; GO:0086050; P:membrane repolarization during bundle of His cell action potential; ISO:RGD.
DR   GO; GO:0086052; P:membrane repolarization during SA node cell action potential; ISO:RGD.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IDA:RGD.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IDA:RGD.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IMP:RGD.
DR   GO; GO:0055075; P:potassium ion homeostasis; IMP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0051259; P:protein complex oligomerization; IMP:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISO:RGD.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:RGD.
DR   GO; GO:0043266; P:regulation of potassium ion transport; ISO:RGD.
DR   GO; GO:0019229; P:regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004052; K_chnl_volt-dep_Kv1.5.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF250; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY A MEMBER 5; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01512; KV15CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Ion channel; Ion transport; Isopeptide bond; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation; Voltage-gated channel.
FT   CHAIN           1..602
FT                   /note="Potassium voltage-gated channel subfamily A member
FT                   5"
FT                   /id="PRO_0000053989"
FT   TOPO_DOM        1..238
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        239..260
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        261..314
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        315..336
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        337..347
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        348..368
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        369..384
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        385..405
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        406..420
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        421..442
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        443..456
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   INTRAMEM        457..468
FT                   /note="Helical; Name=Pore helix"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   INTRAMEM        469..476
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        477..483
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        484..512
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        513..602
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   REGION          1..202
FT                   /note="Tetramerization domain"
FT                   /evidence="ECO:0000250|UniProtKB:P22460"
FT   REGION          58..107
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          407..420
FT                   /note="S4-S5 linker"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   REGION          523..543
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           469..474
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   MOTIF           600..602
FT                   /note="PDZ-binding"
FT   COMPBIAS        523..539
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         81
FT                   /note="Phosphoserine; by CK2 and PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         535
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         546
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         569
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   LIPID           337
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        212
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P22460"
FT   CROSSLNK        525
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P22460"
FT   MUTAGEN         600..602
FT                   /note="TDL->AAA: Loss of interaction with DLG1."
FT                   /evidence="ECO:0000269|PubMed:11709425"
FT   CONFLICT        553
FT                   /note="C -> S (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   602 AA;  66553 MW;  6A784535FF226ED7 CRC64;
     MEISLVPLEN GSAMTLRGGG EAGASCVQTP RGECGCPPTS GLNNQSKETL LRGRTTLEDA
     NQGGRPLPPM AQELPQPRRL SAEDEEGEGD PGLGTVEEDQ APQDAGSLHH QRVLINISGL
     RFETQLGTLA QFPNTLLGDP AKRLHYFDPL RNEYFFDRNR PSFDGILYYY QSGGRLRRPV
     NVSLDVFADE IRFYQLGDEA MERFREDEGF IKEEEKPLPR NEFQRQVWLI FEYPESSGSA
     RAIAIVSVLV ILISIITFCL ETLPEFRDER ELLRHPPVPP QPPAPAPGIN GSVSGALSSG
     PTVAPLLPRT LADPFFIVET TCVIWFTFEL LVRFFACPSK AEFSRNIMNI IDVVAIFPYF
     ITLGTELAEQ QPGGGGQNGQ QAMSLAILRV IRLVRVFRIF KLSRHSKGLQ ILGKTLQASM
     RELGLLIFFL FIGVILFSSA VYFAEADNHG SHFSSIPDAF WWAVVTMTTV GYGDMRPITV
     GGKIVGSLCA IAGVLTIALP VPVIVSNFNY FYHRETDHEE QAALKEEQGN QRRESGLDTG
     GQRKVSCSKA SFCKTGGSLE SSDSIRRGSC PLEKCHLKAK SNVDLRRSLY ALCLDTSRET
     DL
//
